RecruitingNCT06285500
Umbrella Study for Single Patient Treatments in Oncology
UNIQUE: Umbrella N-of-1 Tumor Trials - Umbrella Protocol for Oncology Single Patient Protocols
Sponsor
University Health Network, Toronto
Enrollment
400 participants
Start Date
Feb 1, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of this study is to collect data for assessing the improvement of the overall response rate for the overall cohorts and the proportion of patients accessing precision targeted therapy.
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- Patient's existing genomic information from tumor molecular profiling will be discussed in the hospital expert molecular tumor board rounds consisting of representatives from specialist genomic profiling and medical oncology departments to decide N of 1 treatment for the patient. The discussion will surround the best next therapeutic option in the patient's cancer subtype with or without clear standard of care guidelines. Therefore, specific eligibility criteria aside from individual patient's medical history is not applicable.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERPatient-specific treatments
Treatment will be decided specifically for the patient based on biomarker test results.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06285500
Related Trials
Genetic Analysis of Uncommon Disease Presentations in Non-US Populations
NCT065959401 location
A Study of PHN-012 in Patients With Advanced Solid Tumors
NCT0712787413 locations
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
NCT0573508018 locations
BEhavioral and Adherence Model for Improving Quality, Health Outcomes and Cost-Effectiveness of healthcaRe
NCT0685690210 locations
SPECT Imaging for Pharmacokinetics and dosimEtry Towards TREATment Optimization
NCT063890971 location